Aardvark Therapeutics AARD
NASDAQ AARD
$1.37 +0.02 (+1.48%)
At close: Nov 10, 2026 · 4:00 PM EST

Aardvark Therapeutics (AARD) Preferred Stock Liabilities (2024)

Updated

Aardvark Therapeutics (AARD) recorded Preferred Stock Liabilities of $126.76 million in Q4 2024, unchanged from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Preferred Stock Liabilities (2024) Analysis & Trends

Starting with Q1 2024, Aardvark Therapeutics' Preferred Stock Liabilities history includes 4 quarters.

  • Quarterly Preferred Stock Liabilities has ranged from $43.9 million in Q1 2024 to $126.85 million in Q2 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $126.76 million (Q3 2024), $126.85 million (Q2 2024) and $43.9 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Aardvark Therapeutics 30.58 Mn -43.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 126.76 Mn
Sep 30, 2024 126.76 Mn
Jun 30, 2024 126.85 Mn
Mar 31, 2024 43.90 Mn
API Access

Aardvark Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=AARD&period=max&api_key=YOUR_API_KEY